Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
Selumetinib-D7 is an isotopic labelled compound of Selumetinib (S254000), a tight-binding, uncompetitive inhibitor of mitogen-activated protein kinase kinases (MEK) 1 and 2 currently in clinical development. It is useful as biomarker in human lung cancer cell. Potent MEK inhibitor.